679 related articles for article (PubMed ID: 20638287)
21. New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity.
Riyadh SM; Farghaly TA; Abdallah MA; Abdalla MM; Abd El-Aziz MR
Eur J Med Chem; 2010 Mar; 45(3):1042-50. PubMed ID: 20022411
[TBL] [Abstract][Full Text] [Related]
22. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
Kumar V; Jaggi M; Singh AT; Madaan A; Sanna V; Singh P; Sharma PK; Irchhaiya R; Burman AC
Eur J Med Chem; 2009 Aug; 44(8):3356-62. PubMed ID: 19361894
[TBL] [Abstract][Full Text] [Related]
23. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.
Al-Tel TH
Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086
[TBL] [Abstract][Full Text] [Related]
25. Tyrosinase inhibitory polyphenols from roots of Morus lhou.
Jeong SH; Ryu YB; Curtis-Long MJ; Ryu HW; Baek YS; Kang JE; Lee WS; Park KH
J Agric Food Chem; 2009 Feb; 57(4):1195-203. PubMed ID: 19166303
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
[TBL] [Abstract][Full Text] [Related]
28. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
Bekhit AA; Ashour HM; Abdel Ghany YS; Bekhit Ael-D; Baraka A
Eur J Med Chem; 2008 Mar; 43(3):456-63. PubMed ID: 17532544
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of 5-benzylidene barbiturate derivatives on mushroom tyrosinase and their antibacterial activities.
Yan Q; Cao R; Yi W; Chen Z; Wen H; Ma L; Song H
Eur J Med Chem; 2009 Oct; 44(10):4235-43. PubMed ID: 19552984
[TBL] [Abstract][Full Text] [Related]
32. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
Al-Saadi MS; Rostom SA; Faidallah HM
Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, anti-inflammatory and antimicrobial evaluation of novel 1-acetyl-3,5-diaryl-4,5-dihydro (1H) pyrazole derivatives bearing urea, thiourea and sulfonamide moieties.
Keche AP; Hatnapure GD; Tale RH; Rodge AH; Kamble VM
Bioorg Med Chem Lett; 2012 Nov; 22(21):6611-5. PubMed ID: 23026000
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors.
Liu J; Wu F; Chen L; Hu J; Zhao L; Chen C; Peng L
Bioorg Med Chem Lett; 2011 Apr; 21(8):2376-9. PubMed ID: 21411319
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety.
Bhat KS; Poojary B; Prasad DJ; Naik P; Holla BS
Eur J Med Chem; 2009 Dec; 44(12):5066-70. PubMed ID: 19822384
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2009 Dec; 17(23):7909-14. PubMed ID: 19875299
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors.
Bharate SB; Mahajan TR; Gole YR; Nambiar M; Matan TT; Kulkarni-Almeida A; Balachandran S; Junjappa H; Balakrishnan A; Vishwakarma RA
Bioorg Med Chem; 2008 Aug; 16(15):7167-76. PubMed ID: 18625560
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]